[Federal Register Volume 79, Number 62 (Tuesday, April 1, 2014)]
[Notices]
[Pages 18317-18318]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-07170]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-382]


Controlled Substances: 2014 Established Aggregate Production 
Quotas for Three Temporarily Controlled Synthetic Phenethylamines

AGENCY: Drug Enforcement Administration (DEA), Department of Justice.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice establishes the initial 2014 aggregate production 
quotas for three temporarily controlled synthetic phenethylamines, 25B-
NBOMe, 25C-NBOMe, and 25I-NBOMe.

DATES: Effective Date: April 1, 2014.

FOR FURTHER INFORMATION CONTACT: Ruth A. Carter, Office of Diversion 
Control, Drug Enforcement Administration; Mailing Address: 8701 
Morrissette Drive, Springfield, Virginia 22152, Telephone: (202) 598-
6812.

SUPPLEMENTARY INFORMATION:

Background

    Section 306 of the Controlled Substances Act (CSA) (21 U.S.C. 826) 
requires the Attorney General to establish aggregate production quotas 
for each basic class of controlled substance listed in schedules I and 
II and for the list I chemicals ephedrine, pseudoephedrine, and 
phenylpropanolamine. The Attorney General has delegated this authority 
to the Administrator of the DEA, 28 CFR 0.100, who in turn has 
redelegated that authority to the Deputy Administrator of the DEA, 28 
CFR part 0, subpt. R, App.
    On November 15, 2013, the DEA published in the Federal Register a 
final order to temporarily place three synthetic phenethylamines, 25B-
NBOMe, 25C-NBOMe, and 25I-NBOMe, into schedule I of the CSA (78 FR 
68716), making all regulations pertaining to schedule I controlled 
substances applicable to the manufacture of 25B-NBOMe, 25C-NBOMe, and 
25I-NBOMe, including the requirement to obtain a manufacturing quota 
pursuant to 21 CFR part 1303.
    The 2014 aggregate production quotas for 25B-NBOMe, 25C-NBOMe, and 
25I-NBOMe represent those quantities to be manufactured in the United 
States in 2014 to provide for the estimated medical, scientific, 
research, and industrial needs of the United States, lawful export 
requirements, and the establishment and maintenance of reserve stocks.
    On January 30, 2014, the DEA published a notice titled, 
``Controlled Substances: 2014 Proposed Aggregate Production Quota for 
Three Temporarily Controlled Synthetic Phenethylamines'' in the Federal 
Register (79 FR 4958). That notice proposed the 2014 aggregate

[[Page 18318]]

production quotas for 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe. Interested 
persons were invited to comment on or object to the proposed aggregate 
production quotas for 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe on or before 
March 3, 2014. No comments were received.

Analysis for 2014 Established Aggregate Production Quotas

    In determining the 2014 aggregate production quotas for 25B-NBOMe, 
25C-NBOMe, and 25I-NBOMe, the DEA has taken into consideration the 
factors set forth at 21 CFR 1303.11, pursuant to 21 U.S.C. 826(a), and 
other relevant factors, including 2014 export requirements, industrial 
use, applications for quotas, as well as information on research and 
product development requirements.
    Pursuant to 21 U.S.C. 826 and in accordance with 21 CFR 1303.11, 
the Deputy Administrator hereby establishes the 2014 aggregate 
production quotas for the 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe, 
expressed in grams of anhydrous acid or base, as follows:

------------------------------------------------------------------------
                                                            Established
                 Basic class--schedule I                    2014 quota
------------------------------------------------------------------------
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-                              15 g.
 methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B;
 Cimbi-36)..............................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-                             15 g.
 methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C;
 Cimbi-82)..............................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-                               15 g.
 methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I;
 Cimbi-5)...............................................
------------------------------------------------------------------------

    In accordance with 21 CFR 1303.13, upon consideration of the 
relevant factors, the Deputy Administrator may adjust the 2014 
aggregate production quotas for 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe as 
needed.

    Dated: March 24, 2014.
Thomas M. Harrigan,
Deputy Administrator.
[FR Doc. 2014-07170 Filed 3-31-14; 8:45 am]
BILLING CODE 4410-09-P